← Eichor
Condition: Biliary Dyskinesia Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Biliary Dyskinesia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

QST Study: Predicting Treatment Response in Chronic Pancreatitis Using Quantitative Sensory Testing
NA · 2 location(s) · Anna Evans Phillips · NCT03434392Pharmacokinetics, Bioequivalence, and Safety Study of Trimedat® 76,95 mg Orally Disintegrating Tablets and Trimedat® 100
Phase 1 · 1 location(s) · Valenta Pharm JSC · NCT07421011Food-Effect, Single and Multiple Dose Pharmacokinetics, Safety and Tolerability Study of 4-MUST, 128 mg, Tablets in Heal
Phase 1 · 1 location(s) · Valenta Pharm JSC · NCT07594977Efficacy, Safety, and Tolerability of 4-MUST Tablets in Chronic Cholecystitis and Biliary Dyskinesia
Phase 2 · 17 location(s) · Valenta Pharm JSC · NCT06842966Efficacy, Safety, and Tolerability of 4-MUST, 128 mg Tablets in Chronic Cholecystitis and Biliary Dyskinesia
Phase 3 · 10 location(s) · Valenta Pharm JSC · NCT07595003Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168Evaluation of the Use of a Biodegradable Endoprothesis in the Prevention of Post-Endoscopic Retrograde CholoangioPancrea
NA · 1 location(s) · Institut Paoli-Calmettes · NCT03977779Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)
Phase N/A · 1 location(s) · Seattle Children's Hospital · NCT06315179
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.